TFM
SGMO

TFC Financial Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

TFC Financial Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,620
Closed -$3.11K – 1045
2025
Q3 		$3.11K Buy
+4,620
New +$2.49K ﹤0.01% 504

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TFC Financial Management's SGMO Position: Q4 2025 in Review

TFC Financial Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2025, closing a stake of 4,620 shares — an estimated $3.11K sold.

TFC Financial Management first reported a position in SGMO in Q3 2025 and held it in 1 quarter. The position peaked at $3.11K in Q3 2025. 105 funds tracked by Wall St. Rank hold SGMO as of Q4 2025.

  • TFC Financial Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • TFC Financial Management sold 4,620 SANGAMO THERAPEUTICS INC shares in Q4 2025, an estimated $3.11K.
  • TFC Financial Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2025 and held it in 1 quarter.
  • TFC Financial Management's SANGAMO THERAPEUTICS INC position peaked at $3.11K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2025.

Based on TFC Financial Management's 13F filing for Q4 2025, filed 23 Jan 2026.